Outset Medical, Inc.

Outset Medical, Inc.

OM·NASDAQ

$4.60

-6.3%
HealthcareMedical - Devices

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

At a Glance

Live Snapshot
Market Cap$85.27M
EPS-5.3700
P/E Ratio-0.86
Earnings Date08/05/2026

om

Gross Profit

Last Annual Value

46.75M

3-Year CAGR

38%

5-Year CAGR

41%

10-Year CAGR

25%

Outset Medical, Inc.

Outset Medical, Inc. Competitors Analysis of Gross Profit

OM · NASDAQ
CompanyGross Profit
CAGR 3Y
CAGR 5Y
CAGR 10Y
46.75M
17.3%43.8%N/A 
7.51M
-37.6%-2.7%N/A
CVRX logo
CVRx, Inc.
NASDAQ:CVRX
48.34M
13.5%38.8%N/A
49.97M
11.0%12.8%10.8%
33.09M
32.1%32.8%44.9%
2.22B
1.5%8.0%6.5%
64.96M
-3.8%0.1%23.7%
INGN logo
Inogen, Inc.
NASDAQ:INGN
165.89M
9.4%-1.2%5.5%
-8.44M
N/AN/AN/A
153.97M
10.9%16.0%23.4%
-2.37M
N/AN/AN/A
Outset Medical, Inc.

Outset Medical, Inc. Fair Value Envelope

OM · NASDAQ

Our analysis suggests that OM has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.6, this represents a potential HIDDEN relative to our calculated worth for Outset Medical, Inc..

Intrinsic Value
Current Price: $4.6